{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-01-10T12:22:09.364205+00:00",
  "news": [
    {
      "title": "How The Vertex Pharmaceuticals (VRTX) Story Is Shifting With New Analyst Targets And CF Outlook - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQMlFQeG9ZMHRlNU1ENGEzNDdRUmlpN0w5YUFhdlZsaURCam9Jam4tNUliaDJzRU5fRlNJMUwzcjdQSUR4SW1GZVRLdDlRM3JXVjl1S01IcHNGd0h5R09ETzBQaGUtOWQzRl9wcFNPZ1FsVV9JQTZobE1FVWVjUTB0UWxoaHFtM1NVUjlmMEZtS2RpZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxQMlFQeG9ZMHRlNU1ENGEzNDdRUmlpN0w5YUFhdlZsaURCam9Jam4tNUliaDJzRU5fRlNJMUwzcjdQSUR4SW1GZVRLdDlRM3JXVjl1S01IcHNGd0h5R09ETzBQaGUtOWQzRl9wcFNPZ1FsVV9JQTZobE1FVWVjUTB0UWxoaHFtM1NVUjlmMEZtS2RpZw?oc=5\" target=\"_blank\">How The Vertex Pharmaceuticals (VRTX) Story Is Shifting With New Analyst Targets And CF Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-10T02:48:45+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Insider Sell: Ourania Tatsis Sells 4,500 Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNN0NKeDl6d1RiM3RDcTM0V0tJWXpDd3RlYkZmeXdERlhpSkM2WmhoMXA0ZGx3S2JSVFV6OWFZSzhtU3FTbHpNWWxOc2JNWnV4Y0NRSTFiTTRWaE1kaVdodWt3SlN3QlNwSUdtRF9IaURPYlZRZ3NieExMZGFGZHJIU0F2U3dyREhBR05NdEZwd19YbVQ0YkFpc20wWHVGc1AwQ1hiY0tpNjZYS1hyT3ZzXzJDM09FNThETm5N?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNN0NKeDl6d1RiM3RDcTM0V0tJWXpDd3RlYkZmeXdERlhpSkM2WmhoMXA0ZGx3S2JSVFV6OWFZSzhtU3FTbHpNWWxOc2JNWnV4Y0NRSTFiTTRWaE1kaVdodWt3SlN3QlNwSUdtRF9IaURPYlZRZ3NieExMZGFGZHJIU0F2U3dyREhBR05NdEZwd19YbVQ0YkFpc20wWHVGc1AwQ1hiY0tpNjZYS1hyT3ZzXzJDM09FNThETm5N?oc=5\" target=\"_blank\">Insider Sell: Ourania Tatsis Sells 4,500 Shares of Vertex Pharmaceuticals Inc (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-01-10T00:09:47+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Vertex Pharmaceuticals: The Cost Of Growing Beyond Cystic Fibrosis (Rating Downgrade) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPLVdHR2NERXlCU29uY0dOYkttUlo3N0kybENYa3U3ZHpFWWN6X3pBT3gyeWVraDN1Rk5pMHU0Y3ppd3NaX3FnLUJXYVllckNYS29MblpyeC1uaW41ejB0Q1NHXzJXcEpyX0pBMFZnZHdCZENwMEhQWlVkYXNnbHd6R3JmN3NqXzRmRWloSEkzZWdZRDhxVUxUaXpiRDJMQ3FRWXgzdDc1RjFVQ0JEVGEtVE5DZktfQXlWMTBveFpGblE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPLVdHR2NERXlCU29uY0dOYkttUlo3N0kybENYa3U3ZHpFWWN6X3pBT3gyeWVraDN1Rk5pMHU0Y3ppd3NaX3FnLUJXYVllckNYS29MblpyeC1uaW41ejB0Q1NHXzJXcEpyX0pBMFZnZHdCZENwMEhQWlVkYXNnbHd6R3JmN3NqXzRmRWloSEkzZWdZRDhxVUxUaXpiRDJMQ3FRWXgzdDc1RjFVQ0JEVGEtVE5DZktfQXlWMTBveFpGblE?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: The Cost Of Growing Beyond Cystic Fibrosis (Rating Downgrade)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2026-01-08T08:54:50+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Our Science | Video Series - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE40aEVYaDN2bnhWQklQMlRJT3BHT3lBUUsyWlZWR0c4bDFVYVlPdkVIZ1YwamdIeXR6Vzd2eXBROVJLUnJxU3ZKWVlfTnVHUDFFeGVBZi1yNGNzVjRB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiXEFVX3lxTE40aEVYaDN2bnhWQklQMlRJT3BHT3lBUUsyWlZWR0c4bDFVYVlPdkVIZ1YwamdIeXR6Vzd2eXBROVJLUnJxU3ZKWVlfTnVHUDFFeGVBZi1yNGNzVjRB?oc=5\" target=\"_blank\">Our Science | Video Series</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-12-19T13:07:09+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Is Up 6.8% After IgA Nephropathy Outlook Upgrade - Has The Bull Case Changed? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Is Up 6.8% After IgA Nephropathy Outlook Upgrade - Has The Bull Case Changed?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-08T18:55:01+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5\" target=\"_blank\">Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-09T20:11:58+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why - Finviz",
      "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNQk5YYjBqM0ZiUmRKRnZNeTdDeDk5M1hBZjZ1UkVyYzc2N1JhQjJxNG5XclVVQUozQjlFLThRMDJiTEhBWXRCS3VtelYxZjlwTzdqZXF4LVZtODhKYUszVENaTDQxaE9Yb0lYMzFwdkgtNWpPamMxY1BBRDRaTW9LOFhpZVYtbGJXUzFrRmJiaw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxNQk5YYjBqM0ZiUmRKRnZNeTdDeDk5M1hBZjZ1UkVyYzc2N1JhQjJxNG5XclVVQUozQjlFLThRMDJiTEhBWXRCS3VtelYxZjlwTzdqZXF4LVZtODhKYUszVENaTDQxaE9Yb0lYMzFwdkgtNWpPamMxY1BBRDRaTW9LOFhpZVYtbGJXUzFrRmJiaw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Finviz</font>",
      "published": "2026-01-06T21:27:10+00:00",
      "source": "Finviz"
    },
    {
      "title": "Wolfe Research Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSHFrdmVSazZGVGxza3hHYVotQ2lKM2d1UThCMHJDd3lzWFRJXzBmallQQWhjb3lkdmRhbWNOV3h4RDNFamF2cnpJdGRUajRRcWtiMHozeDVlN292T3Y0NS1iaVFqbHFuZGFyakM0UzdDVDRCczFRWkM1ZzZ6ZEttOUR3dV9BWU4xQk1Z?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSHFrdmVSazZGVGxza3hHYVotQ2lKM2d1UThCMHJDd3lzWFRJXzBmallQQWhjb3lkdmRhbWNOV3h4RDNFamF2cnpJdGRUajRRcWtiMHozeDVlN292T3Y0NS1iaVFqbHFuZGFyakM0UzdDVDRCczFRWkM1ZzZ6ZEttOUR3dV9BWU4xQk1Z?oc=5\" target=\"_blank\">Wolfe Research Upgrades Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-06T15:22:00+00:00",
      "source": "Nasdaq"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5\" target=\"_blank\">Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-05-06T07:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-01-09",
      "close": 463.8599853515625
    },
    "history": [
      {
        "date": "2025-12-31",
        "close": 453.3599853515625
      },
      {
        "date": "2026-01-02",
        "close": 452.1300048828125
      },
      {
        "date": "2026-01-05",
        "close": 448.79998779296875
      },
      {
        "date": "2026-01-06",
        "close": 468.3800048828125
      },
      {
        "date": "2026-01-07",
        "close": 484.1499938964844
      },
      {
        "date": "2026-01-08",
        "close": 469.67999267578125
      },
      {
        "date": "2026-01-09",
        "close": 463.8599853515625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}